Over 25 states are investigating Express Scripts' (NASDAQ:ESRX) proposed $29.1B acquisition of Medco (NYSE:MHS) for possible antitrust violations, Bloomberg reports. Five of the states, including New York and California, are considering lawsuits to challenge the deal should the FTC approve it.